APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prophylactic Gamma Globulin

Compare research editions
View pricing & licenses

Selected research

Industry Research

Prophylactic Gamma Globulin Industry Research Report 2026

Report ID 174029060522 December 2025139 pages

Choose your research edition.

Industry ResearchProphylactic Gamma Globulin Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Prophylactic Gamma Globulin Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Prophylactic Gamma Globulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prophylactic Gamma Globulin Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Prophylactic Gamma Globulin Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Prophylactic Gamma Globulin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Prophylactic Gamma Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Prophylactic Gamma Globulin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Prophylactic Gamma Globulin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Prophylactic Gamma Globulin include CNBG, Takeda, Shenzhen Weiguang Biological, Beijing Tiantan Biological, CBPO, Sichuan Yuanda Shuyang, Shanghai RAAS, Pacific Shuanglin Bio-pharmacy and Grifols, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Prophylactic Gamma Globulin market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Prophylactic Gamma Globulin Market by Company

CNBG

Takeda

Shenzhen Weiguang Biological

Beijing Tiantan Biological

CBPO

Sichuan Yuanda Shuyang

Shanghai RAAS

Pacific Shuanglin Bio-pharmacy

Grifols

Hualan Biological

Beijing Bohui Innovation Biotechnology

Baxter

Octapharma

LFB Group

Kedrion Biopharma

BPL

Biotest

ADMA Biologics

Prophylactic Gamma Globulin Segment by Type

IVIg Liquid

IVIg Powder

Prophylactic Gamma Globulin Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

Prophylactic Gamma Globulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prophylactic Gamma Globulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prophylactic Gamma Globulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prophylactic Gamma Globulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Prophylactic Gamma Globulin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Prophylactic Gamma Globulin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Prophylactic Gamma Globulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Prophylactic Gamma Globulin Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Prophylactic Gamma Globulin Sales (k units) of Manufacturers (2021-2026) Table 7. Global Prophylactic Gamma Globulin Sales Market Share by Manufacturers (2021-2026) Table 8. Global Prophylactic Gamma Globulin Revenue of Manufacturers (2021-2026) Table 9. Global Prophylactic Gamma Globulin Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Prophylactic Gamma Globulin Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Prophylactic Gamma Globulin Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Prophylactic Gamma Globulin, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Prophylactic Gamma Globulin, Product Type & Application Table 14. Global Prophylactic Gamma Globulin Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Prophylactic Gamma Globulin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. CNBG Company Information Table 19. CNBG Business Overview Table 20. CNBG Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. CNBG Prophylactic Gamma Globulin Product Portfolio Table 22. CNBG Recent Developments Table 23. Takeda Company Information Table 24. Takeda Business Overview Table 25. Takeda Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Takeda Prophylactic Gamma Globulin Product Portfolio Table 27. Takeda Recent Developments Table 28. Shenzhen Weiguang Biological Company Information Table 29. Shenzhen Weiguang Biological Business Overview Table 30. Shenzhen Weiguang Biological Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Shenzhen Weiguang Biological Prophylactic Gamma Globulin Product Portfolio Table 32. Shenzhen Weiguang Biological Recent Developments Table 33. Beijing Tiantan Biological Company Information Table 34. Beijing Tiantan Biological Business Overview Table 35. Beijing Tiantan Biological Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Beijing Tiantan Biological Prophylactic Gamma Globulin Product Portfolio Table 37. Beijing Tiantan Biological Recent Developments Table 38. CBPO Company Information Table 39. CBPO Business Overview Table 40. CBPO Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. CBPO Prophylactic Gamma Globulin Product Portfolio Table 42. CBPO Recent Developments Table 43. Sichuan Yuanda Shuyang Company Information Table 44. Sichuan Yuanda Shuyang Business Overview Table 45. Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Product Portfolio Table 47. Sichuan Yuanda Shuyang Recent Developments Table 48. Shanghai RAAS Company Information Table 49. Shanghai RAAS Business Overview Table 50. Shanghai RAAS Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Shanghai RAAS Prophylactic Gamma Globulin Product Portfolio Table 52. Shanghai RAAS Recent Developments Table 53. Pacific Shuanglin Bio-pharmacy Company Information Table 54. Pacific Shuanglin Bio-pharmacy Business Overview Table 55. Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Product Portfolio Table 57. Pacific Shuanglin Bio-pharmacy Recent Developments Table 58. Grifols Company Information Table 59. Grifols Business Overview Table 60. Grifols Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Grifols Prophylactic Gamma Globulin Product Portfolio Table 62. Grifols Recent Developments Table 63. Hualan Biological Company Information Table 64. Hualan Biological Business Overview Table 65. Hualan Biological Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Hualan Biological Prophylactic Gamma Globulin Product Portfolio Table 67. Hualan Biological Recent Developments Table 68. Beijing Bohui Innovation Biotechnology Company Information Table 69. Beijing Bohui Innovation Biotechnology Business Overview Table 70. Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Product Portfolio Table 72. Beijing Bohui Innovation Biotechnology Recent Developments Table 73. Baxter Company Information Table 74. Baxter Business Overview Table 75. Baxter Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Baxter Prophylactic Gamma Globulin Product Portfolio Table 77. Baxter Recent Developments Table 78. Octapharma Company Information Table 79. Octapharma Business Overview Table 80. Octapharma Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Octapharma Prophylactic Gamma Globulin Product Portfolio Table 82. Octapharma Recent Developments Table 83. LFB Group Company Information Table 84. LFB Group Business Overview Table 85. LFB Group Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. LFB Group Prophylactic Gamma Globulin Product Portfolio Table 87. LFB Group Recent Developments Table 88. Kedrion Biopharma Company Information Table 89. Kedrion Biopharma Business Overview Table 90. Kedrion Biopharma Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Kedrion Biopharma Prophylactic Gamma Globulin Product Portfolio Table 92. Kedrion Biopharma Recent Developments Table 93. BPL Company Information Table 94. BPL Business Overview Table 95. BPL Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. BPL Prophylactic Gamma Globulin Product Portfolio Table 97. BPL Recent Developments Table 98. Biotest Company Information Table 99. Biotest Business Overview Table 100. Biotest Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Biotest Prophylactic Gamma Globulin Product Portfolio Table 102. Biotest Recent Developments Table 103. ADMA Biologics Company Information Table 104. ADMA Biologics Business Overview Table 105. ADMA Biologics Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. ADMA Biologics Prophylactic Gamma Globulin Product Portfolio Table 107. ADMA Biologics Recent Developments Table 108. Global Prophylactic Gamma Globulin Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Prophylactic Gamma Globulin Sales by Region (2021-2026) & (k units) Table 110. Global Prophylactic Gamma Globulin Sales Market Share by Region (2021-2026) Table 111. Global Prophylactic Gamma Globulin Sales by Region (2027-2032) & (k units) Table 112. Global Prophylactic Gamma Globulin Sales Market Share by Region (2027-2032) Table 113. Global Prophylactic Gamma Globulin Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Prophylactic Gamma Globulin Revenue Market Share by Region (2021-2026) Table 115. Global Prophylactic Gamma Globulin Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Prophylactic Gamma Globulin Revenue Market Share by Region (2027-2032) Table 117. North America Prophylactic Gamma Globulin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Prophylactic Gamma Globulin Sales by Country (2021-2026) & (k units) Table 119. North America Prophylactic Gamma Globulin Sales by Country (2027-2032) & (k units) Table 120. North America Prophylactic Gamma Globulin Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Prophylactic Gamma Globulin Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Prophylactic Gamma Globulin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Prophylactic Gamma Globulin Sales by Country (2021-2026) & (k units) Table 124. Europe Prophylactic Gamma Globulin Sales by Country (2027-2032) & (k units) Table 125. Europe Prophylactic Gamma Globulin Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Prophylactic Gamma Globulin Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Prophylactic Gamma Globulin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Prophylactic Gamma Globulin Sales by Country (2021-2026) & (k units) Table 129. Asia Pacific Prophylactic Gamma Globulin Sales by Country (2027-2032) & (k units) Table 130. Asia Pacific Prophylactic Gamma Globulin Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Prophylactic Gamma Globulin Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Prophylactic Gamma Globulin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Prophylactic Gamma Globulin Sales by Country (2021-2026) & (k units) Table 134. South America Prophylactic Gamma Globulin Sales by Country (2027-2032) & (k units) Table 135. South America Prophylactic Gamma Globulin Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Prophylactic Gamma Globulin Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Prophylactic Gamma Globulin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Prophylactic Gamma Globulin Sales by Country (2021-2026) & (k units) Table 139. Middle East and Africa Prophylactic Gamma Globulin Sales by Country (2027-2032) & (k units) Table 140. Middle East and Africa Prophylactic Gamma Globulin Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Prophylactic Gamma Globulin Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Prophylactic Gamma Globulin Sales by Type (2021-2026) & (k units) Table 143. Global Prophylactic Gamma Globulin Sales by Type (2027-2032) & (k units) Table 144. Global Prophylactic Gamma Globulin Sales Market Share by Type (2021-2026) Table 145. Global Prophylactic Gamma Globulin Sales Market Share by Type (2027-2032) Table 146. Global Prophylactic Gamma Globulin Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Prophylactic Gamma Globulin Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Prophylactic Gamma Globulin Revenue Market Share by Type (2021-2026) Table 149. Global Prophylactic Gamma Globulin Revenue Market Share by Type (2027-2032) Table 150. Global Prophylactic Gamma Globulin Price by Type (2021-2026) & (US$/unit) Table 151. Global Prophylactic Gamma Globulin Price by Type (2027-2032) & (US$/unit) Table 152. Global Prophylactic Gamma Globulin Sales by Application (2021-2026) & (k units) Table 153. Global Prophylactic Gamma Globulin Sales by Application (2027-2032) & (k units) Table 154. Global Prophylactic Gamma Globulin Sales Market Share by Application (2021-2026) Table 155. Global Prophylactic Gamma Globulin Sales Market Share by Application (2027-2032) Table 156. Global Prophylactic Gamma Globulin Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Prophylactic Gamma Globulin Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Prophylactic Gamma Globulin Revenue Market Share by Application (2021-2026) Table 159. Global Prophylactic Gamma Globulin Revenue Market Share by Application (2027-2032) Table 160. Global Prophylactic Gamma Globulin Price by Application (2021-2026) & (US$/unit) Table 161. Global Prophylactic Gamma Globulin Price by Application (2027-2032) & (US$/unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Prophylactic Gamma Globulin Distributors List Table 165. Prophylactic Gamma Globulin Customers List Table 166. Prophylactic Gamma Globulin Industry Trends Table 167. Prophylactic Gamma Globulin Industry Drivers Table 168. Prophylactic Gamma Globulin Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Prophylactic Gamma Globulin Product Image Figure 5. Global Prophylactic Gamma Globulin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Prophylactic Gamma Globulin Market Size (2021-2032) & (US$ Million) Figure 7. Global Prophylactic Gamma Globulin Sales (2021-2032) & (k units) Figure 8. Global Prophylactic Gamma Globulin Average Price (US$/unit) & (2021-2032) Figure 9. IVIg Liquid Product Image Figure 10. IVIg Powder Product Image Figure 11. Autoimmune Disease Product Image Figure 12. Immunodeficiency Product Image Figure 13. Acute Infection Product Image Figure 14. Global Prophylactic Gamma Globulin Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Prophylactic Gamma Globulin, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Prophylactic Gamma Globulin Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Prophylactic Gamma Globulin Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Prophylactic Gamma Globulin Sales by Region in 2025 Figure 20. Global Prophylactic Gamma Globulin Revenue by Region in 2025 Figure 21. North America Prophylactic Gamma Globulin Market Size by Country in 2025 Figure 22. North America Prophylactic Gamma Globulin Sales Market Share by Country (2021-2032) Figure 23. North America Prophylactic Gamma Globulin Revenue Market Share by Country (2021-2032) Figure 24. United States Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Prophylactic Gamma Globulin Market Size by Country in 2025 Figure 28. Europe Prophylactic Gamma Globulin Sales Market Share by Country (2021-2032) Figure 29. Europe Prophylactic Gamma Globulin Revenue Market Share by Country (2021-2032) Figure 30. Germany Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Prophylactic Gamma Globulin Market Size by Country in 2025 Figure 41. Asia Pacific Prophylactic Gamma Globulin Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Prophylactic Gamma Globulin Revenue Market Share by Country (2021-2032) Figure 43. China Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Prophylactic Gamma Globulin Market Size by Country in 2025 Figure 52. South America Prophylactic Gamma Globulin Sales Market Share by Country (2021-2032) Figure 53. South America Prophylactic Gamma Globulin Revenue Market Share by Country (2021-2032) Figure 54. Brazil Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Prophylactic Gamma Globulin Market Size by Country in 2025 Figure 59. Middle East and Africa Prophylactic Gamma Globulin Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Prophylactic Gamma Globulin Revenue Market Share by Country (2021-2032) Figure 61. Egypt Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Prophylactic Gamma Globulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Prophylactic Gamma Globulin Sales Market Share by Type (2021-2032) Figure 67. Global Prophylactic Gamma Globulin Revenue Market Share by Type (2021-2032) Figure 68. Global Prophylactic Gamma Globulin Price (US$/unit) by Type (2021-2032) Figure 69. Global Prophylactic Gamma Globulin Sales Market Share by Application (2021-2032) Figure 70. Global Prophylactic Gamma Globulin Revenue Market Share by Application (2021-2032) Figure 71. Global Prophylactic Gamma Globulin Price (US$/unit) by Application (2021-2032) Figure 72. Prophylactic Gamma Globulin Value Chain Figure 73. Prophylactic Gamma Globulin Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Prophylactic Gamma Globulin Industry Opportunities and Challenges

Scope & coverage.

Types
  • IVIg Liquid
  • IVIg Powder
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
Companies covered
  • CNBG
  • Takeda
  • Shenzhen Weiguang Biological
  • Beijing Tiantan Biological
  • CBPO
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Pacific Shuanglin Bio-pharmacy
  • Grifols
  • Hualan Biological
  • Beijing Bohui Innovation Biotechnology
  • Baxter
  • Octapharma
  • LFB Group
  • Kedrion Biopharma
  • BPL
  • Biotest
  • ADMA Biologics

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Prophylactic Gamma Globulin Market Size (2021-2032)
  4. 2.2.2 Global Prophylactic Gamma Globulin Sales (2021-2032)
  5. 2.2.3 Global Prophylactic Gamma Globulin Market Average Price (2021-2032)
  6. 2.3 Prophylactic Gamma Globulin by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 IVIg Liquid
  9. 2.3.3 IVIg Powder
  10. 2.4 Prophylactic Gamma Globulin by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Autoimmune Disease
  13. 2.4.3 Immunodeficiency
  14. 2.4.4 Acute Infection
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Prophylactic Gamma Globulin Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Prophylactic Gamma Globulin Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Prophylactic Gamma Globulin Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Prophylactic Gamma Globulin Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Prophylactic Gamma Globulin Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Prophylactic Gamma Globulin, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Prophylactic Gamma Globulin, Product Type & Application
  8. 3.8 Global Manufacturers of Prophylactic Gamma Globulin, Established Date
  9. 3.9 Global Prophylactic Gamma Globulin Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 CNBG
  2. 4.1.1 CNBG Company Information
  3. 4.1.2 CNBG Business Overview
  4. 4.1.3 CNBG Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 CNBG Prophylactic Gamma Globulin Product Portfolio
  6. 4.1.5 CNBG Recent Developments
  7. 4.2 Takeda
  8. 4.2.1 Takeda Company Information
  9. 4.2.2 Takeda Business Overview
  10. 4.2.3 Takeda Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Takeda Prophylactic Gamma Globulin Product Portfolio
  12. 4.2.5 Takeda Recent Developments
  13. 4.3 Shenzhen Weiguang Biological
  14. 4.3.1 Shenzhen Weiguang Biological Company Information
  15. 4.3.2 Shenzhen Weiguang Biological Business Overview
  16. 4.3.3 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Product Portfolio
  18. 4.3.5 Shenzhen Weiguang Biological Recent Developments
  19. 4.4 Beijing Tiantan Biological
  20. 4.4.1 Beijing Tiantan Biological Company Information
  21. 4.4.2 Beijing Tiantan Biological Business Overview
  22. 4.4.3 Beijing Tiantan Biological Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Beijing Tiantan Biological Prophylactic Gamma Globulin Product Portfolio
  24. 4.4.5 Beijing Tiantan Biological Recent Developments
  25. 4.5 CBPO
  26. 4.5.1 CBPO Company Information
  27. 4.5.2 CBPO Business Overview
  28. 4.5.3 CBPO Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 CBPO Prophylactic Gamma Globulin Product Portfolio
  30. 4.5.5 CBPO Recent Developments
  31. 4.6 Sichuan Yuanda Shuyang
  32. 4.6.1 Sichuan Yuanda Shuyang Company Information
  33. 4.6.2 Sichuan Yuanda Shuyang Business Overview
  34. 4.6.3 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Product Portfolio
  36. 4.6.5 Sichuan Yuanda Shuyang Recent Developments
  37. 4.7 Shanghai RAAS
  38. 4.7.1 Shanghai RAAS Company Information
  39. 4.7.2 Shanghai RAAS Business Overview
  40. 4.7.3 Shanghai RAAS Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Shanghai RAAS Prophylactic Gamma Globulin Product Portfolio
  42. 4.7.5 Shanghai RAAS Recent Developments
  43. 4.8 Pacific Shuanglin Bio-pharmacy
  44. 4.8.1 Pacific Shuanglin Bio-pharmacy Company Information
  45. 4.8.2 Pacific Shuanglin Bio-pharmacy Business Overview
  46. 4.8.3 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Product Portfolio
  48. 4.8.5 Pacific Shuanglin Bio-pharmacy Recent Developments
  49. 4.9 Grifols
  50. 4.9.1 Grifols Company Information
  51. 4.9.2 Grifols Business Overview
  52. 4.9.3 Grifols Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Grifols Prophylactic Gamma Globulin Product Portfolio
  54. 4.9.5 Grifols Recent Developments
  55. 4.10 Hualan Biological
  56. 4.10.1 Hualan Biological Company Information
  57. 4.10.2 Hualan Biological Business Overview
  58. 4.10.3 Hualan Biological Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Hualan Biological Prophylactic Gamma Globulin Product Portfolio
  60. 4.10.5 Hualan Biological Recent Developments
  61. 4.11 Beijing Bohui Innovation Biotechnology
  62. 4.11.1 Beijing Bohui Innovation Biotechnology Company Information
  63. 4.11.2 Beijing Bohui Innovation Biotechnology Business Overview
  64. 4.11.3 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Product Portfolio
  66. 4.11.5 Beijing Bohui Innovation Biotechnology Recent Developments
  67. 4.12 Baxter
  68. 4.12.1 Baxter Company Information
  69. 4.12.2 Baxter Business Overview
  70. 4.12.3 Baxter Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Baxter Prophylactic Gamma Globulin Product Portfolio
  72. 4.12.5 Baxter Recent Developments
  73. 4.13 Octapharma
  74. 4.13.1 Octapharma Company Information
  75. 4.13.2 Octapharma Business Overview
  76. 4.13.3 Octapharma Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Octapharma Prophylactic Gamma Globulin Product Portfolio
  78. 4.13.5 Octapharma Recent Developments
  79. 4.14 LFB Group
  80. 4.14.1 LFB Group Company Information
  81. 4.14.2 LFB Group Business Overview
  82. 4.14.3 LFB Group Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 LFB Group Prophylactic Gamma Globulin Product Portfolio
  84. 4.14.5 LFB Group Recent Developments
  85. 4.15 Kedrion Biopharma
  86. 4.15.1 Kedrion Biopharma Company Information
  87. 4.15.2 Kedrion Biopharma Business Overview
  88. 4.15.3 Kedrion Biopharma Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Kedrion Biopharma Prophylactic Gamma Globulin Product Portfolio
  90. 4.15.5 Kedrion Biopharma Recent Developments
  91. 4.16 BPL
  92. 4.16.1 BPL Company Information
  93. 4.16.2 BPL Business Overview
  94. 4.16.3 BPL Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 BPL Prophylactic Gamma Globulin Product Portfolio
  96. 4.16.5 BPL Recent Developments
  97. 4.17 Biotest
  98. 4.17.1 Biotest Company Information
  99. 4.17.2 Biotest Business Overview
  100. 4.17.3 Biotest Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Biotest Prophylactic Gamma Globulin Product Portfolio
  102. 4.17.5 Biotest Recent Developments
  103. 4.18 ADMA Biologics
  104. 4.18.1 ADMA Biologics Company Information
  105. 4.18.2 ADMA Biologics Business Overview
  106. 4.18.3 ADMA Biologics Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 ADMA Biologics Prophylactic Gamma Globulin Product Portfolio
  108. 4.18.5 ADMA Biologics Recent Developments
5 Global Prophylactic Gamma Globulin Market Scenario by Region
  1. 5.1 Global Prophylactic Gamma Globulin Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Prophylactic Gamma Globulin Sales by Region: 2021-2032
  3. 5.2.1 Global Prophylactic Gamma Globulin Sales by Region: 2021-2026
  4. 5.2.2 Global Prophylactic Gamma Globulin Sales by Region: 2027-2032
  5. 5.3 Global Prophylactic Gamma Globulin Revenue by Region: 2021-2032
  6. 5.3.1 Global Prophylactic Gamma Globulin Revenue by Region: 2021-2026
  7. 5.3.2 Global Prophylactic Gamma Globulin Revenue by Region: 2027-2032
  8. 5.4 North America Prophylactic Gamma Globulin Market Facts & Figures by Country
  9. 5.4.1 North America Prophylactic Gamma Globulin Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Prophylactic Gamma Globulin Sales by Country (2021-2032)
  11. 5.4.3 North America Prophylactic Gamma Globulin Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Prophylactic Gamma Globulin Market Facts & Figures by Country
  16. 5.5.1 Europe Prophylactic Gamma Globulin Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Prophylactic Gamma Globulin Sales by Country (2021-2032)
  18. 5.5.3 Europe Prophylactic Gamma Globulin Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Prophylactic Gamma Globulin Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Prophylactic Gamma Globulin Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Prophylactic Gamma Globulin Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Prophylactic Gamma Globulin Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Prophylactic Gamma Globulin Market Facts & Figures by Country
  41. 5.7.1 South America Prophylactic Gamma Globulin Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Prophylactic Gamma Globulin Sales by Country (2021-2032)
  43. 5.7.3 South America Prophylactic Gamma Globulin Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Prophylactic Gamma Globulin Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Prophylactic Gamma Globulin Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Prophylactic Gamma Globulin Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Prophylactic Gamma Globulin Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Prophylactic Gamma Globulin Sales by Type (2021-2032)
  2. 6.1.1 Global Prophylactic Gamma Globulin Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Prophylactic Gamma Globulin Sales Market Share by Type (2021-2032)
  4. 6.2 Global Prophylactic Gamma Globulin Revenue by Type (2021-2032)
  5. 6.2.1 Global Prophylactic Gamma Globulin Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Prophylactic Gamma Globulin Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Prophylactic Gamma Globulin Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Prophylactic Gamma Globulin Sales by Application (2021-2032)
  2. 7.1.1 Global Prophylactic Gamma Globulin Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Prophylactic Gamma Globulin Sales Market Share by Application (2021-2032)
  4. 7.2 Global Prophylactic Gamma Globulin Revenue by Application (2021-2032)
  5. 7.2.1 Global Prophylactic Gamma Globulin Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Prophylactic Gamma Globulin Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Prophylactic Gamma Globulin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Prophylactic Gamma Globulin Value Chain Analysis
  2. 8.1.1 Prophylactic Gamma Globulin Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Prophylactic Gamma Globulin Production Mode & Process
  5. 8.2 Prophylactic Gamma Globulin Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Prophylactic Gamma Globulin Distributors
  8. 8.2.3 Prophylactic Gamma Globulin Customers
9 Global Prophylactic Gamma Globulin Analyzing Market Dynamics
  1. 9.1 Prophylactic Gamma Globulin Industry Trends
  2. 9.2 Prophylactic Gamma Globulin Industry Drivers
  3. 9.3 Prophylactic Gamma Globulin Industry Opportunities and Challenges
  4. 9.4 Prophylactic Gamma Globulin Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst